01011.HK
China NT Pharma Group Company Limited
HKSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
HKD 0.36
+0.00%Margins
Gross margin
16.5%
EBITDA margin
-37.2%
EBIT margin
-39.0%
Net margin
-76.9%
FCF margin
-15.4%
24.6%
Return on equity
-4.2%
Return on assets
-6.2%
Return on invested capital
0.07x
Asset turnover
-HKD 6.2M
Cash from operations
HKD 0.02
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026